CMU
VERA icon

Carnegie Mellon University’s Vera Therapeutics VERA Stock Holding History

Carnegie Mellon University’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-16,060
Closed -$693K – 5
2024
Q1 		$693K Hold
16,060
– – 0.87% 2
2023
Q4 		$247K Hold
16,060
– – 0.3% 3
2023
Q3 		$220K Hold
16,060
– – 0.28% 4
2023
Q2 		$258K Hold
16,060
– – 0.36% 3
2023
Q1 		$125K Hold
16,060
– – 0.08% 4
2022
Q4 		$311K Hold
16,060
– – 0.17% 3
2022
Q3 		$342K Hold
16,060
– – 0.19% 4
2022
Q2 		$219K Hold
16,060
– – 0.11% 4
2022
Q1 		$377K Sell
16,060
-16,060
-50% -$346K 0.16% 4
2021
Q4 		$858K Buy
+32,120
New +$710K 0.34% 4

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Carnegie Mellon University's VERA Position: Q2 2024 in Review

Carnegie Mellon University sold out of Vera Therapeutics (VERA) in Q2 2024, closing a stake of 16,060 shares — an estimated $693K sold.

Carnegie Mellon University first reported a position in VERA in Q4 2021 and held it in 10 quarters. The position peaked at $858K in Q4 2021. 171 funds tracked by Wall St. Rank hold VERA as of Q2 2024.

  • Carnegie Mellon University reported no remaining Vera Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Carnegie Mellon University sold 16,060 Vera Therapeutics shares in Q2 2024, an estimated $693K.
  • Carnegie Mellon University first reported a position in Vera Therapeutics in Q4 2021 and held it in 10 quarters.
  • Carnegie Mellon University's Vera Therapeutics position peaked at $858K in Q4 2021.
  • 171 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2024.

Based on Carnegie Mellon University's 13F filing for Q2 2024, filed 8 Aug 2024.